Lung Function Decline in Early HIV Infection: Impact of Antiretroviral Drug Timing and Drug Regimen

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2019 Dec 17

PMID 31841641

Citations 7

Authors

Ken M Kunisaki

Jason V Baker

Gary Collins

David M MacDonald

Elzbieta Bakowska

Kamal Marhoum El Filali

Eriobu Nnakelu

Alberto La Rosa

John E Connett

Affiliations

Soon will be listed here.

Citing Articles

Does the Recovery of Respiratory Viruses Impact Pulmonary Function at Baseline and 1-, 6-, and 12-Month Follow-Up in People Living with HIV and Pneumonia?.

Rodriguez-Sabogal I, Cabrera R, Marin D, Lopez L, Aguilar Y, Gomez G Viruses. 2024; 16(3).

PMID: 38543710 PMC: 10974101. DOI: 10.3390/v16030344.

Pulmonary function tests and their associated factors in people living with HIV at Jimma medical center; Ethiopia: a comparative cross-sectional study.

Teshome Azezew M, Gobena T, Mengstie M, Mulat E Front Reprod Health. 2023; 5:1178304.

PMID: 37901155 PMC: 10611469. DOI: 10.3389/frph.2023.1178304.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV.

MacDonald D, Samorodnitsky S, Wendt C, Baker J, Collins G, Kruk M Sci Rep. 2023; 13(1):4749.

PMID: 36959289 PMC: 10036615. DOI: 10.1038/s41598-023-29739-x.

Faster lung function decline in people living with HIV despite adequate treatment: a longitudinal matched cohort study.

Thudium R, Ronit A, Afzal S, Colak Y, Forman J, Mendo F Thorax. 2023; 78(6):535-542.

PMID: 36639241 PMC: 10191974. DOI: 10.1136/thorax-2022-218910.

Chronic Human Immunodeficiency Virus Infection Is Associated with Accelerated Decline of Forced Expiratory Volume in 1 Second among Women but Not among Men: A Longitudinal Cohort Study in Uganda.

McNeill J, Okello S, Sentongo R, Kakuhikire B, Tsai A, Christiani D Ann Am Thorac Soc. 2022; 19(10):1779-1783.

PMID: 35767026 PMC: 9753523. DOI: 10.1513/AnnalsATS.202111-1275RL.

References

Lundgren J, Babiker A, Gordin F, Emery S, Grund B, Sharma S . Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015; 373(9):795-807. PMC: 4569751. DOI: 10.1056/NEJMoa1506816. View

George M, Kannass M, Huang L, Sciurba F, Morris A . Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One. 2009; 4(7):e6328. PMC: 2709444. DOI: 10.1371/journal.pone.0006328. View

Kunisaki K, Niewoehner D, Collins G, Aagaard B, Atako N, Bakowska E . Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. Lancet Respir Med. 2016; 4(12):980-989. PMC: 5279910. DOI: 10.1016/S2213-2600(16)30319-8. View

Tashkin D, Altose M, Connett J, Kanner R, Lee W, Wise R . Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1996; 153(6 Pt 1):1802-11. DOI: 10.1164/ajrccm.153.6.8665038. View

Prescott E, Bjerg A, Andersen P, Lange P, Vestbo J . Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997; 10(4):822-7. View